AmerisourceBergen Corporation (ABC) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Pharmaceutical DistributionInternational Healthcare SolutionsAnimal HealthOther Segments
012B25B38B50B62B75B88B100BQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Revenue by Geography

U.S. Healthcare SolutionsInternational Healthcare SolutionsOther Segments
012B25B38B50B62B75B88B100BQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
025B50B75B100B125B150B175B200BQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Margin (%)

Gross MarginOperating MarginNet Income Margin
0124568910Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Operating Expenses

Selling General And Administrative ExpensesOther Expenses
0500M1B2B2B2B3B4B4BQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

EBITDA

EBITDA
0250M500M750M1B1B2B2B2BQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

EPS

EPSEPS Diluted
02581012151820Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Revenue Variation (%)

Revenue Variation
-20-16-13-10-6-2148Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
06251K2K2K3K4K4K5KQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Revenue YoY Variation (%)

Revenue YoY Variation
-3-102457810Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
0255075100125150175200Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Price-to-Earning Ratio

P/E Ratio
-60-48-35-22-102152840Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
048111519222630Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Per Share Metrics

Operating IncomeTotal Other Income Expenses NetNet Income
0625M1B2B2B3B4B4B5BQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
075150225300375450525600Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
💰 Cash Flow Statement

Operating Cash Flow

Capex To RevenueStock Based Compensation To Revenue
000001111Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
01B2B3B4B5B6B7B8BQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Cash Flow to Debt Ratio

Cash At End Of Period
0750M2B2B3B4B4B5B6BQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026
🏦 Balance Sheet
📈 Key Metrics